Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 453-456, October 2003

Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer☆☆☆★

Assistant Clinical Physician, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Newyork, NY, USA

Associate Attending Physician, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cencer Center, Newyork, NY, USA

Abstracted from: Citron M., Berry D., Cirrincione C., et al. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. Journal of Clinical Oncology 2003;21:1431–1439.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Not specified.

☆☆ For correspondence: Marc L. Citron, MD, ProHEALTH Care Associates, LLP, 2800 Marcus Ave, Lake Success, NY 11042; E-mail: mcitron@prohealthcare.com.

★ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(03)00164-6

doi:10.1016/S0305-7372(03)00164-6

Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 453-456, October 2003

Article Tools